Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia

被引：1
作者：
Martinez de Victoria, Emilio Ortega [1 ,2 ]
机构：
[1] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Serv Endocrinol & Nutr, Barcelona, Spain
[2] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain
来源：
ENDOCRINOLOGIA DIABETES Y NUTRICION | 2017年 / 64卷 / 07期
关键词：
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR EVENTS; RISK; DISCONTINUATION; METAANALYSIS; ALIROCUMAB; RATIONALE; STATINS;
D O I：
10.1016/j.endinu.2017.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：341 / 344
页数：4
相关论文
共 25 条
  • [1] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
    Abifadel, M
    Varret, M
    Rabès, JP
    Allard, D
    Ouguerram, K
    Devillers, M
    Cruaud, C
    Benjannet, S
    Wickham, L
    Erlich, D
    Derré, A
    Villéger, L
    Farnier, M
    Beucler, I
    Bruckert, E
    Chambaz, J
    Chanu, B
    Lecerf, JM
    Luc, G
    Moulin, P
    Weissenbach, J
    Prat, A
    Krempf, M
    Junien, C
    Seidah, NG
    Boileau, C
    [J]. NATURE GENETICS, 2003, 34 (02) : 154 - 156
  • [2] aemps, Agencia espanola de medicamentos y productos sanitarios
  • [3] [Anonymous], N ENGL J MED
  • [4] Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia
    Ascaso, Juan F.
    [J]. ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (06): : 255 - 257
  • [5] Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
    Boekholdt, S. Matthijs
    Hovingh, G. Kees
    Mora, Samia
    Arsenault, Benoit J.
    Amarenco, Pierre
    Pedersen, Terje R.
    LaRosa, John C.
    Waters, David D.
    DeMicco, David A.
    Simes, R. John
    Keech, Antony C.
    Colquhoun, David
    Hitman, Graham A.
    Betteridge, John
    Clearfield, Michael B.
    Downs, John R.
    Colhoun, Helen M.
    Gotto, Antonio M., Jr.
    Ridker, Paul M.
    Grundy, Scott M.
    Kastelein, John J. P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) : 485 - 494
  • [6] CatSalut, SERV CAT SAL
  • [7] Interpretation of the evidence for the efficacy and safety of statin therapy
    Collins, Rory
    Reith, Christina
    Emberson, Jonathan
    Armitage, Jane
    Baigent, Colin
    Blackwell, Lisa
    Blumenthal, Roger
    Danesh, John
    Smith, George Davey
    DeMets, David
    Evans, Stephen
    Law, Malcolm
    MacMahon, Stephen
    Martin, Seth
    Neal, Bruce
    Poulter, Neil
    Preiss, David
    Ridker, Paul
    Roberts, Ian
    Rodgers, Anthony
    Sandercock, Peter
    Schulz, Kenneth
    Sever, Peter
    Simes, John
    Smeeth, Liam
    Wald, Nicholas
    Yusuf, Salim
    Peto, Richard
    [J]. LANCET, 2016, 388 (10059) : 2532 - 2561
  • [8] Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
    Ference, Brian A.
    Majeed, Faisal
    Penumetcha, Raju
    Flack, John M.
    Brook, Robert D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1552 - 1561
  • [9] Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapyA cognitive study of patients enrolled in the FOURIER trial
    Giugliano, Robert P.
    Mach, Francois
    Zavitz, Kenton
    Kurtz, Christopher
    Schneider, Jingjing
    Wang, Huei
    Keech, Anthony
    Pedersen, Terje R.
    Sabatine, Marc S.
    Sever, Peter S.
    Honarpour, Narimon
    Wasserman, Scott M.
    Ott, Brian R.
    [J]. CLINICAL CARDIOLOGY, 2017, 40 (02) : 59 - 65
  • [10] Cardiovascular Health in a Southern Mediterranean European Country A Nationwide Population-Based Study
    Graciani, Auxiliadora
    Leon-Munoz, Luz M.
    Guallar-Castillon, Pilar
    Rodriguez-Artalejo, Fernando
    Banegas, Jose R.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (01): : 90 - 98
123